Page 116 - AN-4-4
P. 116

Advanced Neurology                                                         CAA-related inflammatory case



            similar imaging manifestations, but the patient’s condition   titled “Comparative Study on the Application of Situation
            improved after immunosuppressive treatment, which is   Teaching and Bedside Teaching in Physical Examination
            inconsistent with the characteristics of IVL, such as rapid   Teaching of Neurology Department.”
            disease progression and poor prognosis. Clinically, there
            are CAA-ri patients presenting with stroke-like symptoms   Conflict of interest
            or epileptic seizures. These patients were only given   The authors declare they have no competing interests.
            cerebrovascular and inflammatory treatments, missing
            the chance of receiving immunotherapy at an early stage,   Author contributions
            thereby leading to a decline in their quality of life and even   Conceptualization: All authors
            poor prognosis.
                                                               Investigation: Yue Zhang
              CAA-ri is potentially treatable. Clinically, short-  Writing – original draft: Yue Zhang
            term high-dose glucocorticoid shock therapy is the first   Writing – review & editing: Zhong Zhao, Chen-hong Qiu
            choice. Baskaran et al.  demonstrated sustained cognitive
                              12
            improvement lasting over 24  months through a 5-day   Ethics approval and consent to participate
            high-dose methylprednisolone pulse therapy followed by   Written informed consent was obtained from the patient
            a long-term maintenance regimen.  The therapeutic effect   following his participation.
                                       12
            of glucocorticoids on CAA-ri is also demonstrated in this
            patient. Glucocorticoid treatment can not only relieve   Consent for publication
            the patient’s clinical symptoms and improve imaging   The patient consented to the publication of his data.
            manifestations  but  also  reduce  the  risk  of  recurrence.
            Some research indicates that the recurrence rate of CAA-ri   Availability of data
            can also be reduced in  patients  who only receive  short-
            term corticosteroid treatment.  For long-term treatment,   Not applicable.
                                    11
            immunosuppressants such as azathioprine, methotrexate,   Further disclosure
            and mycophenolate mofetil can be added to reduce
                                                                                                    th
            the patient’s dependence on hormones.  Experimental   Part of the findings have been presented at the 26  Academic
                                             13
            glucocorticoid  treatment can reduce  the  necessity  of   Conference on Neurology of Jiangsu Medical Association
            brain biopsy for patients. The biopsy is only considered   on December 28, 2023, at Xuzhou, Jiangsu, China.
            when there is no significant improvement in patients after
            3 weeks of corticosteroid treatment. 8             References
                                                               1.   Yiyuan X, Rong W, Xin G, et al. Research on the pathological
            4. Conclusion                                         characteristics and mechanism of inflammation associated
            At present, there are relatively few reports of CAA-ri   with cerebral amyloid angiopathy.  Chin J Geriatr Heart
            in China. The incidence of this pathological condition   Brain Vessels. 2022;24(7):775-777.
            has been underestimated, and misdiagnosis is common      doi: 10.3969/j.issn.1009-0126.2022.07.028
            among the affected patients. Therefore, CAA-ri should be   2.   Charidimou A. Cerebral amyloid angiopathy-related
            considered for the elderly with symptoms such as cognitive   inflammation spectrum disorders: Introduction of
            impairment,  headache,  epileptic  seizures,  mental  and   a novel concept and diagnostic criteria.  Ann Neurol.
            behavioral abnormalities, and focal neurological damage,   2025;97(3):470-474.
            if MRI shows multiple asymmetric leukoencephalopathy      doi: 10.1002/ana.27162
            and microhemorrhages. Further improvement of CSF
            antibody and genetic testing can be carried out for early   3.   Mandybur  TI.  Cerebral  amyloid  angiopathy:  Possible
                                                                             to
                                                                  relationship
                                                                                            vasculitis.
                                                                                 rheumatoid
                                                                                                      Neurology.
            identification, diagnosis, and treatment, so as to improve   1979;29(10):1336-1340.
            the quality of life of patients.
                                                                  doi: 10.1212/wnl.29.10.1336
            Acknowledgments                                    4.   Wu JJ, Yao M, Ni J. Cerebral amyloid angiopathy-related
            None.                                                 inflammation: Current status and future implications. Chin
                                                                  Med J (Engl). 2021;134(6):646-654.
            Funding                                               doi: 10.1097/CM9.0000000000001427
            This work was supported by an educational research   5.   Theodorou A, Tsibonakis A, Pateras IS,  et al. Multiple
            project of Suzhou Municipal Hospital (Slyyjy202301)   cerebral microinfarcts: An uncommon presentation of


            Volume 4 Issue 4 (2025)                        110                           doi: 10.36922/AN025080015
   111   112   113   114   115   116   117   118   119   120